USD 19.5 billion
Report ID:
SQMIG35H2316 |
Region:
Global |
Published Date: November, 2024
Pages:
209
|Tables:
116
|Figures:
73
Global Cell Analysis Market size was valued at USD 19.5 billion in 2022 and is poised to grow from USD 21.61 billion in 2023 to USD 49.08 billion by 2031, growing at a CAGR of 10.80% during the forecast period (2024-2031).
The growth of cell analysis market can be attributed to increasing incidence of the chronic diseases, technological advances in cellular analysis, and the rise of drug discovery activities. Cell analysis has emerged as an important tool, it is used to identify therapeutic options for chronic diseases. Therefore, the increasing prevalence of chronic diseases such as cardiovascular diseases, cancers, autoimmune diseases, and rheumatoid arthritis may drive the demand for cellular analysis in 2024.
Advances in the use of cellular diagnostics, from the early detection of cancer to the development of therapeutic tools have increased the popularity of cancer. Patients with cancer are fueling the efforts to improve in cellular studies for the advanced healing and therapeutic functions. For example, Serum Detect, a cancer detection organization, was nominated for early detection of T-cellular testing by way of the American Association for Cancer Research (AACR) in March 2024. Such a growing effort which healthcare companies are creating to increase the use of cellular diagnostics in drive market growth during the forecast period.
Furthermore, technological advances in cell analysis have enabled the development of passive bioseparation systems that improve the accuracy and efficiency of results and advanced technologies.
Global Market Size
USD 19.5 billion
Largest Segment
Software
Fastest Growth
Hospitals and Clinical Testing Laboratories
Growth Rate
10.80%
To get more reports on the above market click here to Buy The Report
Global Cell Analysis Market is segmented into Product & Service, Technique, Process, end user, and region. By Product & Service, the market is classified into Reagents & Consumables, Instruments, Accessories, Software, and Services. Depending on the Technique, it is categorized into Flow Cytometry, PCR, Cell Microarrays, Microscopy, Spectrophotometry, High-Content Screening, and Other Techniques. By Process, the market is classified into Cell Identification, Cell Viability, Cell Signaling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, and Single-Cell Analysis. According to End User, the market is divided into Pharmaceutical and Biotechnology Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Process
The cell identification segment dominated the market with the largest revenue share of 4.81% in 2023. Biological analysis is the first step in any downstream analysis, making it an important process for analysis. As the importance increases further, cell detection can be performed in many ways because it is a convenient procedure. These cellular recognition methods further contribute to growth. The cell identification segment makes a speciality of recognizing and classifying diverse cell kinds primarily based on the precise markers, floor proteins, and morphology, which is essential in fields like cancer research, immunology, and regenerative medication.
Single-cell analysis is expected to drive the fastest growth over the forecast period. Single-cell analysis allows researchers to examine individual cells, revealing striking differences in a group of seemingly homogeneous cells. This hidden diversity can be important for cell function, disease pathogenesis and drug. Moreover, many market players are developing advanced solutions for single cell analysis, contributing significantly to the growth of the segment. In October 2021, PerkinElmer and Honeycomb Biotechnologies announced they were launching HIV tests. This solution introduced single-cell analysis by allowing researchers to capture, store and analyze sensitive cell types.
The single-cell analysis segment delves deeper into information mobile heterogeneity by way of analyzing character cells at the genomic, transcriptomic, and proteomic. This is critical for uncovering insights into complicated natural strategies which includes tumor development and immune responses and driving innovations in personalized medication.
Analysis by End-Use
The pharmaceutical and biotechnology companies segment dominated the market with the largest share of 40.3%. This can be attributed to increasing drug discovery efforts, greater investment in R&D, and the increased focus of these companies on the personalized medicine by pharmaceutical and natural companies biotechnology and results in significantly increased drug discovery activity. Biotechnology, being an integral part of drug discovery, is used by these companies for a variety of purposes, increasing the share segment of pharmaceutical and biotechnology companies.
Hospitals and clinical laboratories are expected to witness the fastest growth during the forecast period. The rapid progress may be attributed to the growing demand for biomarker discovery, early analysis and the sickness development. Bioanalysis can assist people to become aware of unique molecules or mobile characteristics, allowing clinics to predict how a patient will respond to specific treatments. This allows healthcare companies to individualize treatment plans for every patient, enhancing the patient results. Similarly, superior mobile screening methods will permit the healthcare experts to diagnose sicknesses more accurately and efficaciously, in addition increasing their importance in medical and medical trials.
To get detailed analysis on other segments, Request For Free Sample Report
North America ruled the market with 40% in 2023 owing to several drug discovery activities, excellent penetration of advanced cell analysis technologies, presence of key marketplace players and the excessive incidence of persistent illnesses within the region. According to estimates from Statistics Canada, in 2021, approximately 45.1% of Canadians have been at the least one foremost continual contamination. Such high prevalence of chronic diseases necessitates the development of effective advanced therapies, thus driving market growth.
The cell analysis market will witness lucrative growth during the forecast period. This growth can be attributed to the presence of key market players, supportive regulatory framework, increasing R&D efforts by pharmaceutical and biotechnology companies. Moreover, there are many key market players in the US, leading to cell research technology flows into the country's medical biotechnology industry. Increasingly, these market players are introducing their advanced technologies in the country, further increasing their acceptance and driving the market growth. Asia Pacific region in the cell analysis market is anticipated to witness the quickest increase at a CAGR of 10.87% from 2024 to 2031. The region is predicted to witness substantial growth in the market, driven through elements including the growing investments in the healthcare infrastructure, excessive incidence of persistent sicknesses, and growing scientific trials. According to the American College of Cardiology Foundation facts published in June 2021, cardiovascular ailment-related deaths in Asia rose from 5.6 million to 10.8 million. Such growing prevalence of persistent illnesses is predicted to pressure the demand for cellular evaluation technology over the forecast duration.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Growing Demand for Generic Medicines
Increasing Incidence of Chronic Diseases
Restraints
Increased Cost of Equipment and Machinery
Complex Legal Requirements
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the cell analysis marketplace is extraordinarily dynamic, with key players and emerging corporations driving innovation the use of the superior technologies and strategies. Leading manufacturers which include Thermo Fisher Scientific, Becton, Dickinson and Company (BD), and Danaher Corporation dominate the market with superior offerings of drift cytometry, cellular imaging, and single-cell analysis tools. These producers recognition on product development and sustainability to strengthen their portfolios and many others.
Top Player’s Company Profiles
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the cell analysis marketplace is witnessing robust growth driven via high demand for personalized drugs and the growing occurrence of persistent diseases. Personalized medicine is transforming healthcare, and cell studies plays a key role in customizing remedies primarily based at the individual genetic profiles. At the same time, the increasing burden of chronic sicknesses is pushing demand for advanced cellular diagnostic tools to study the mechanisms of disease. However, challenges including high system charges and complicated regulatory necessities stay predominant limitations to market enlargement. The market is also experiencing massive trends consisting of advances in single-cell analysis and integration of AI-ML technology, which permit innovation and transformational evaluation.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 19.5 billion |
Market size value in 2031 | USD 49.08 billion |
Growth Rate | 10.80% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Cell Analysis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell Analysis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell Analysis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cell Analysis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2316
sales@skyquestt.com
USA +1 351-333-4748